الصحيفة
الصحيفة
Ready to play
Ready to play
India is strengthening its presence in the global health sector through low-cost pharmaceutical manufacturing, expanded health coverage, and investment in digital innovation and scientific research, offering an approach it believes can be adapted in countries of the Global South. Its pharmaceutical exports reached $31 billion in fiscal year 2025–26, and its medicines reach more than 190 countries. India also supplies about one-fifth of the world’s generic medicines. The Jan Aushadhi network has more than 20,000 centers that sell medicines for 50 to 80 percent less than their branded equivalents. On the digital front, e-Sanjeevani has delivered more than 500 million remote consultations, while the CoWIN platform has processed more than two billion vaccination records. The experience suggests that improving access to treatment requires bringing together affordable medicines and distribution networks, health coverage, and digital solutions, alongside technology and expertise transfer and the development of local capacity.
Notice: This Is an AI-Generated Summary
Comments (0)